Money is the one shortage you can always fix later. Print it, borrow it, tax it, and it comes back. A disease surveillance network that has scattered does not come back. That asymmetry is what the cuts to the CDC and NIH are actually spending.
A reading applying the treatise’s argument about how a shortage of money, left standing, destroys real capacity. Companion to The Seed Corn Problem, which makes the same case about research funding. Conditional, falsifiable, not policy advice.
Here is the argument in one line. There are two kinds of shortage, and only one of them is reversible.
A shortage of money is temporary by nature. You can print it, borrow it, tax it, or wait. When the money comes back, whatever it was going to buy is still there waiting.
A shortage of capacity is not like that. Once the laboratory closes and the people who worked in it take other jobs in other cities, restoring the budget restores nothing at all. You have the money back. You do not have them back.
The cuts to the CDC, NIH and federal research are that second kind of shortage, applied to an unusual asset. Public health is not a factory. What it produces is a state of readiness. And readiness is a thing you either have on the day, or you do not.
The manager parallel
The treatise gives central banks a job title: the manager of financial scarcity. Their task is to stop a shortage of money becoming a shortage of everything else. And crucially, that only works if the institution is already credible before the crisis, because nobody can build credibility during one.
The CDC does the same job on the other side of the ledger. It watches for the first sign of a real shortage: a new pathogen, a contaminated food supply, a resistant infection. Then it moves fast enough to stop that shortage spreading through everything else.
Same function. Same requirement. It has to already exist on the morning the thing arrives.
A disease surveillance network is not a service you can switch off and switch back on. It is a capacity that either exists continuously, or does not exist at all on the day of the outbreak.
What is being cut
The proposed 2026 budget cuts the CDC by 53 percent, from about $9.2 billion to $4.3 billion, and closes more than sixty programs. Its staff of 13,363 would be cut roughly in half. FoodNet, which watches for foodborne outbreaks, drops from tracking eight pathogens to two.
The NIH would lose roughly 40 percent of its budget, from $46 billion to $27.9 billion, with grant funding down 43 percent.
The asymmetry
And here is the number that frames all of it, which this framework’s own rules require be stated plainly rather than buried.
Harvard economists put the total cost of COVID-19 to the United States at around $16 trillion.
The prevention arithmetic
$16T
Estimated US economic cost, COVID-19 pandemic
vs.
~$55B
Annual CDC + NIH budget (FY2024, pre-cuts)
vs.
~$30B
Proposed annual CDC + NIH budget after FY2026 cuts
The pandemic cost approximately 290 years of the pre-cut annual public health research budget. The $25B in proposed annual savings is wiped out if the reduced capacity contributes to even one COVID-scale event per six centuries, or one $25B-scale outbreak per year. A single large listeria outbreak (2011 cantaloupe: estimates in the hundreds of millions of dollars) already approaches or exceeds the annual operating budget of the foodborne surveillance network that would have detected it faster. Sources: JAMA (COVID-19 cost); HHS/NIH budget documents; TFAH analysis.
This framework is not claiming the prevention budget is obviously the right size. It is claiming the argument for cutting it confuses two different kinds of shortage. The deficit is a shortage of money. The surveillance network is a stock of real capacity. And you are proposing to relieve the first by consuming the second.
The wars and the real bind
Two wars are running that matter to American food and energy prices. Both feed the same configuration the treatise describes.
Ukraine is the world’s largest exporter of sunflower oil and a major exporter of wheat and corn. When the fighting started in 2022, global wheat prices jumped roughly 60 percent within days. That is a real shortage. Grain that does not exist cannot be conjured by a central bank.
The Iran conflict added an oil shock on top. Crude rose above $90 a barrel after the escalation in early 2026. Energy prices feed straight into the uncomfortable corner of the treatise’s map, where prices rise and output falls at the same time.
The capacity that disperses
The treatise says exactly what to watch for, and it is not a budget line. In the stage where capacity gets destroyed, the losses show up as people scattering. Epidemiologists taking jobs in industry. Laboratory technicians moving cities. A surveillance network that existed as a set of trained people in specific places simply stops existing, quietly, without anyone announcing it.
University research works the same way. A doctoral student who starts studying infectious disease in 2024 finishes in 2029 or 2030, if the funding holds. If it does not, they do not pause. They take a job. And the specific person who would have spent thirty years becoming the world expert on something we have not needed yet simply never becomes that person.
The tariff compounding
And the same administration cutting these budgets has put tariffs on scientific instruments and laboratory supplies, most of which are made in Europe and Asia. So the remaining research money buys less than it did. The cut is larger than the cut.
The falsifiable predictions
The framework makes specific, dated, conditional claims.
One. Cutting FoodNet from eight pathogens to two will mean at least one major foodborne outbreak, campylobacter or listeria or shigella or vibrio or yersinia, gets identified later than it would have been. Watch the interval between first case and first public warning.
Two. Scattering the CDC’s field epidemiologists in 2025 will lengthen the gap between a new pathogen appearing and anyone responding to it. Weeks rather than days. That gap is measurable, and it will be measured.
Three. The long-run cost of the NIH cuts will exceed the money saved within fifteen years, as the pipeline fails to produce treatments and diagnostics that would otherwise have arrived. This one takes until 2041 to settle, which is exactly why it is worth writing down now.
What the framework concludes
The treatise says the manager has to exist and be trusted before the crisis, because you cannot build either during one. The CDC’s network, its people and its standing are that capacity. Cutting them is not saving money. It is spending a reserve, and the bill arrives on a date nobody gets to choose.
One honest qualification. The treatise’s mechanism is about credit: a financial crisis left unrelieved, destroying capacity through distress and forced sales. What is happening here is a deliberate policy choice, not a market failure. The mechanism is the same. The cause is not, and the framework should not pretend otherwise.
The case for the cuts says the deficit is a real problem that has to be dealt with. This framework’s reply is narrow. A deficit is a shortage of money, and money is the one thing a government issuing its own currency can always produce. A dispersed laboratory is not. You are trading something you can always get back for something you cannot.
The factories are standing. The shelves are full. The warehouses are stocked. Whether people go without depends not on the goods but on the rank money holds.
That is the treatise’s last sentence. This piece adds only that some of the things being given up to satisfy money cannot be bought back at any price, and that the bill for them arrives on a date nobody gets to choose.